当前位置:首页 - 行情中心 - 安科生物(300009) - 财务分析 - 现金流量表

安科生物

(300009)

  

流通市值:96.87亿  总市值:131.48亿
流通股本:12.31亿   总股本:16.71亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,649,147,906.41,102,593,087.63511,493,367.952,516,919,971.4
  收到其他与经营活动有关的现金13,487,220.612,230,380.295,657,088.2434,069,524.5
  经营活动现金流入小计1,662,635,1271,114,823,467.92517,150,456.192,550,989,495.9
  购买商品、接受劳务支付的现金240,516,653.22165,843,884.872,636,077.89200,000,902.21
  支付给职工以及为职工支付的现金359,179,108.28255,120,502.44102,873,486.63499,222,102.66
  支付的各项税费157,367,210.37124,803,599.548,302,502.66236,279,907.58
  支付其他与经营活动有关的现金547,545,376.16296,558,597.61152,507,719.2752,266,112.43
  经营活动现金流出小计1,304,608,348.03842,326,584.35376,319,786.381,687,769,024.88
  经营活动产生的现金流量净额358,026,778.97272,496,883.57140,830,669.81863,220,471.02
二、投资活动产生的现金流量:
  收回投资收到的现金1,217,909,914.091,131,909,914.09954,700,0001,150,037,035.43
  取得投资收益收到的现金26,555,170.4123,701,443.7511,499,624.9220,764,621.48
  处置固定资产、无形资产和其他长期资产收回的现金净额1,324,458.15145,485.046,00017,593,923.97
  处置子公司及其他营业单位收到的现金净额2,084.15---
  收到的其他与投资活动有关的现金2,269,482.331,105,395.57467,024.453,299,832.99
  投资活动现金流入小计1,248,061,109.131,156,862,238.45966,672,649.371,191,695,413.87
  购建固定资产、无形资产和其他长期资产支付的现金79,979,604.9343,580,360.2624,168,266.25126,891,933.56
  投资支付的现金1,041,330,092.77923,085,135.151,107,186,0801,516,958,400.48
  支付其他与投资活动有关的现金---845,846.49
  投资活动现金流出小计1,121,309,697.7966,665,495.411,131,354,346.251,644,696,180.53
  投资活动产生的现金流量净额126,751,411.43190,196,743.04-164,681,696.88-453,000,766.66
三、筹资活动产生的现金流量:
  吸收投资收到的现金---23,991,248.28
  取得借款收到的现金120,967,920.8970,967,920.89-7,000,000
  筹资活动现金流入平衡项目00-0
  筹资活动现金流入小计120,967,920.8970,967,920.89-30,991,248.28
  偿还债务支付的现金70,967,920.89--5,000,000
  分配股利、利润或偿付利息支付的现金471,907,719.59427,086,232.449,204,420416,774,267.93
  其中:子公司支付给少数股东的股利、利润44,492,760--3,295,760
  支付其他与筹资活动有关的现金121,302,860.1763,618,708.9342,474,876.3572,945,601.23
  筹资活动现金流出小计664,178,500.65490,704,941.3751,679,296.35494,719,869.16
  筹资活动产生的现金流量净额-543,210,579.76-419,737,020.48-51,679,296.35-463,728,620.88
四、汇率变动对现金及现金等价物的影响-758,997.94-548,881.03-166,960.35-6,894,791.48
五、现金及现金等价物净增加额-59,191,387.342,407,725.1-75,697,283.77-60,403,708
  加:期初现金及现金等价物余额238,201,226.97238,201,226.97238,201,226.97298,604,934.97
  期末现金及现金等价物余额179,009,839.67280,608,952.07162,503,943.2238,201,226.97
补充资料:
  净利润-340,305,904.64-747,338,705.69
  资产减值准备-1,267,065.92-28,045,640.38
  固定资产和投资性房地产折旧-46,983,511.93-82,806,998.99
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-46,983,511.93-82,806,998.99
  无形资产摊销-16,018,493.2-32,721,735.7
  长期待摊费用摊销-1,266,004.04-2,874,413.64
  处置固定资产、无形资产和其他长期资产的损失--149,780.75--6,301,460.04
  固定资产报废损失-147,480.46-383,093.13
  公允价值变动损失--3,319,536.98--1,881,347.93
  财务费用--500,502.55-1,421,146.95
  投资损失--7,238,901.06--18,254,666.16
  递延所得税-3,778,337.29--20,967,934.27
  其中:递延所得税资产减少-3,783,455.63--19,542,147.14
    递延所得税负债增加--5,118.34--1,425,787.13
  存货的减少--33,260,664.43-14,143,928.99
  经营性应收项目的减少--81,007,910.64--129,395,848.59
  经营性应付项目的增加--19,367,418.07-97,031,592.16
  其他-5,499,166.92-24,843,963.77
  现金的期末余额-280,608,952.07-238,201,226.97
  减:现金的期初余额-238,201,226.97-298,604,934.97
  现金及现金等价物的净增加额-42,407,725.1--60,403,708
公告日期2026-10-242026-08-262026-04-242026-03-31
审计意见(境内)标准无保留意见
TOP↑